Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Newcombe

Showing results (41-50 of 194) with videos related to

Pageof 20
Sort By:
Journal of Neuroimmunology|July 1, 1992
Lipocortins (annexins) 1, 2, 4 and 5 are increased in the central nervous system in multiple sclerosisA J Elderfield, J Newcombe, C Bolton, et al.
Journal of Neurochemistry|July 31, 1999
Subunit composition of Kv1 channels in human CNSS K Coleman, J Newcombe, J Pryke, et al.
Neuropathology and Applied Neurobiology|June 1, 1993
Characterization and distribution of phagocytic macrophages in multiple sclerosis plaquesH Li, J Newcombe, N P Groome, et al.
Neuroimage|March 12, 2011
Contrast-to-noise ratios for indices of anisotropy obtained from diffusion MRI: a study with standard clinical b-values at 3TMarta Morgado Correia, Virginia F J Newcombe, Guy B Williams
Statistics in Medicine|June 22, 2021
Bayesian variable selection with a pleiotropic loss function in Mendelian randomizationApostolos Gkatzionis, Stephen Burgess, David V Conti, et al.
Clinical and Experimental Immunology|April 1, 1982
Analysis of immunoglobulin G in multiple sclerosis brain: quantitative and isoelectric focusing studiesP Glynn, H M Gilbert, J Newcombe, et al.
Acta Neurologica Scandinavica|May 1, 1981
Measurement of glial fibrillary acidic protein (GFAP) and anti-GFAP antibodies by solid-phase radioimmunoassaysJ Ruutiainen, J Newcombe, A Salmi, et al.
Neuropathology and Applied Neurobiology|June 7, 2000
Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesionsJ E Simpson, J Newcombe, M L Cuzner, et al.
Biometrics|January 15, 2021
Two-stage penalized regression screening to detect biomarker-treatment interactions in randomized clinical trialsJixiong Wang, Ashish Patel, James M S Wason, et al.
Genetic Epidemiology|July 23, 2019
A flexible and parallelizable approach to genome-wide polygenic risk scoresPaul J Newcombe, Christopher P Nelson, Nilesh J Samani, et al.
Pageof 20

Showing results (41-50 of 194) with videos related to

Sort By:
Pageof 20
Journal of Neuroimmunology|July 1, 1992
Lipocortins (annexins) 1, 2, 4 and 5 are increased in the central nervous system in multiple sclerosisA J Elderfield, J Newcombe, C Bolton, et al.
Journal of Neurochemistry|July 31, 1999
Subunit composition of Kv1 channels in human CNSS K Coleman, J Newcombe, J Pryke, et al.
Neuropathology and Applied Neurobiology|June 1, 1993
Characterization and distribution of phagocytic macrophages in multiple sclerosis plaquesH Li, J Newcombe, N P Groome, et al.
Neuroimage|March 12, 2011
Contrast-to-noise ratios for indices of anisotropy obtained from diffusion MRI: a study with standard clinical b-values at 3TMarta Morgado Correia, Virginia F J Newcombe, Guy B Williams
Statistics in Medicine|June 22, 2021
Bayesian variable selection with a pleiotropic loss function in Mendelian randomizationApostolos Gkatzionis, Stephen Burgess, David V Conti, et al.
Clinical and Experimental Immunology|April 1, 1982
Analysis of immunoglobulin G in multiple sclerosis brain: quantitative and isoelectric focusing studiesP Glynn, H M Gilbert, J Newcombe, et al.
Acta Neurologica Scandinavica|May 1, 1981
Measurement of glial fibrillary acidic protein (GFAP) and anti-GFAP antibodies by solid-phase radioimmunoassaysJ Ruutiainen, J Newcombe, A Salmi, et al.
Neuropathology and Applied Neurobiology|June 7, 2000
Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesionsJ E Simpson, J Newcombe, M L Cuzner, et al.
Biometrics|January 15, 2021
Two-stage penalized regression screening to detect biomarker-treatment interactions in randomized clinical trialsJixiong Wang, Ashish Patel, James M S Wason, et al.
Genetic Epidemiology|July 23, 2019
A flexible and parallelizable approach to genome-wide polygenic risk scoresPaul J Newcombe, Christopher P Nelson, Nilesh J Samani, et al.
Pageof 20